Human Transferrin is a biochemical marker of iron status in the body. Transferrin (TF) is responsible for the transport of iron through the blood to various tissues. It is a blood plasma glycoprotein that plays a central role in iron metabolism. Members of the transferrin family are mostly monomeric glycoproteins, consisting of two lobes capable of binding ferric ions. When the binding sites are empty, transferrin is called apo-transferrin, as opposed to holo-transferrin, when the binding sites are occupied. The aim of this work is to determine the binding constant, number of binding sites and the binding mechanism between Olanzapine (OLZ) and TF by spectroscopic methods (fluorescence and absorption measurements). Results showed that Olanzapine reacts with transferrin and forms a TF-OLZ complex. The binding of olanzapine to transferrin is a spontaneous process. According to the calculated quenching constants, it appears that the quenching mechanism, which involves the formation of a complex, was found to be static. The main interactions between olanzapine and transferrin are hydrogen bonding and weak van der Waals forces.
                    Previous Article in event
            
                            Previous Article in session
            
                    
    
                    Next Article in event
            
                            Next Article in session
            
                    
                                                    
        
                    Investigation of the interaction between olanzapine and human transferrin
                
                                    
                
                
                    Published:
01 November 2023
by MDPI
in 9th International Electronic Conference on Medicinal Chemistry
session General
                
                                    
                        https://doi.org/10.3390/ECMC2023-15682
                                                    (registering DOI)
                                            
                
                
                    Abstract: 
                                    
                        Keywords: Transferrin; Olanzapine; Spectroscopic measurements
                    
                
                
                
                
        
            